Investment-In-Innovation (IN3) Medical Device 360 Dublin to Feature 30+ Start-Ups Seeking Partnership, and Top-Tier Investors and Industry Leaders
April 16-18, 2013, The Shelbourne Dublin
(firmenpresse) - DUBLIN, IRELAND -- (Marketwire) -- 02/26/13 -- , publisher of "The Gray Sheet" and the medtech industry's leading provider of strategic partnership and investment conferences, will host the partnering and investment conference on , at the . This special event, which will bring together a diverse group of medtech's key thought leaders from among corporate business development execs, venture capital and angel investors, start-up entrepreneurs and industry pioneers, will feature a panel discussion:
Despite the dire headlines, venture capitalists are still investing in medtech start-ups, even early stages. Learn what kind of deals the VCs are doing now and in the future and explore medical device investing, financing and exit strategies.
Rationale behind the past few deals: How did they get on the radar?
How are opportunistic and proactive ideas generated in certain clinical spaces?
How does geography weigh-in on the decision to invest?
What stage do certain VCs like to invest in and why?
What is the solution for getting seed-stage investing?
Talking to corporates early to map out your exit strategy.
(moderator), Vice President, Content, Elsevier Business Intelligence; (moderator), Editor-in-Chief, Elsevier Business Intelligence; MSc, PhD, Partner, Seroba Kernel Lifesciences; , Investment Manager, NBGI Ventures; , Managing Partner, Sofinnova Partners; , Partner, Abingworth Management; , Partner, Earlybird Venture Capital; , Managing Partner, Peppermint Venture Partners GmbH.
These interviews will be featured post-conference at , to which a link will be provided to participating companies for their unrestricted use; availability of these video interviews will be broadly promulgated within the medtech industry. All one-on-one interviews with presenting-company CEOs will take place at, and during the IN3 Dublin conference and be organized by , President of Ronald Trahan Associates, Inc. To schedule the free on-camera interviews contact , or call +1-508-359-4005, x108.
An unprecedented number of additional top-tier international dealmakers are also confirmed to attend, including: Bard, Covidien, Edwards Lifesciences, Johnson & Johnson, Sorin, Stryker, Delta Partners, Fountain Healthcare Partners, Gilde, Imperial Innovations, Omnes Capital, Sofinnova, Wellington Partners, and many more. Further, IN3 Dublin will feature presentations by more than 30 early development- to commercial-stage start-up device companies seeking funding and/or strategic partnership. Confirmed presenters to date include: Access Bio, Aerogen, Aerolase, AltaScience, APICA Cardiovascular, Calon Cardio-Technology, Cardiograde, Chronix Biomedical, Clinical Laserthermia Systems, Expanding Orthopedics, FBC Device, Glysure, Humedics, i360medical, InControl Medical, Mainstay Medical, Mederi Therapeutics, MedLumics, Neuravi, Nordocs, Novate Medical, Quanta Fluid Solutions, SpineLab, Technopath, Vascular Flow Technologies, Veryan Medical, and WellBeingz.
Event co-sponsors include , , , , , , , , , , . , and .
Visit for full conference and registration details. Emerging medtech companies that would like to apply to present in Dublin should contact at 949-797-7142, or email
Elsevier Business Intelligence (EBI), an Elsevier company built on the heritage of F-D-C Reports, Windhover Information and Medtech Insight, is a global information supplier providing business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. Through a range of products including publications, conferences, and reports, EBI places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge, by providing the perfect combination of news and information together with penetrating insight and analysis. EBI () has offices in the U.S. in Bridgewater, N.J.; Norwalk, Conn.; Rockville, Md.; and Irvine, Calif.
Contact:
Ronald Trahan, APR
Ronald Trahan Associates Inc.
508-359-4005, x108
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 26.02.2013 - 15:20 Uhr
Sprache: Deutsch
News-ID 233484
Anzahl Zeichen: 0
contact information:
Town:
DUBLIN, IRELAND
Kategorie:
Commercial & Investment Banking
Diese Pressemitteilung wurde bisher 121 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Investment-In-Innovation (IN3) Medical Device 360 Dublin to Feature 30+ Start-Ups Seeking Partnership, and Top-Tier Investors and Industry Leaders"
steht unter der journalistisch-redaktionellen Verantwortung von
Elsevier Business Intelligence (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
